Share

CRYOPRESERVED AUTOLOGOUS BONE MARROW TRANSPLANTATION IN PATIENTS WITH ACUTE NONLYMPHOID LEUKEMIA: CHEMOTHERAPY BEFORE HARVESTING IS THE MAIN FACTOR IN DELAYING HEMATOLOGICAL RECOVERY.

Author(s) : VISANI G.

Type of article: Article

Summary

A COMPARISON WAS MADE BETWEEN 13 PATIENTS WITH ACUTE NONLYMPHOID LEUKEMIAS (ANLL) AND 31 PATIENTS WITH NON-HODGKIN'S LYMPHOMA (NHL) WHOSE BONE MARROW WAS HARVESTED AND CRYOPRESERVED. HEMATOLOGICAL RECOVERY OF ANLL PATIENTS WAS SIMILAR TO THAT OF PRETREATED NHL PATIENTS AND SIGNIFICANTLY SLOWER THAN THAT OF UNTREATED NHL PATIENTS. CHEMOTHERAPY BEFORE HARVEST APPEARS TO BE THE MAIN FACTOR RESPONSIBLE FOR DELAYED RECOVERY AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION IN ANLL.

Details

  • Original title: CRYOPRESERVED AUTOLOGOUS BONE MARROW TRANSPLANTATION IN PATIENTS WITH ACUTE NONLYMPHOID LEUKEMIA: CHEMOTHERAPY BEFORE HARVESTING IS THE MAIN FACTOR IN DELAYING HEMATOLOGICAL RECOVERY.
  • Record ID : 1991-0885
  • Languages: English
  • Source: Cryobiology - vol. 27 - n. 2
  • Publication date: 1990

Links


See other articles in this issue (4)
See the source

Indexing